Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Stent Grafts Market by Product (Endovascular, Synthetic Stent Graft System), by Application (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA)) and by Type (Aorta-uni-iliac (AUI) Stent Grafts, Bifurcated Stent Grafts): Global Opportunity Analysis and Industry Forecast, 2023-2032

A02351

Pages: NA

Charts: NA

Tables: NA

Stent grafts are tubular-shaped devices with metallic frame used during endovascular aneurysm repair (EVAR) procedures. It is a minimally invasive procedure, during which the grafts are implanted in the patients to support the damaged area from rupturing.

The growth of the global stent grafts market is driven by factors such as rise in hypertension, growth in geriatric population, and increase in awareness about aneurysm. In addition, rise in demand for minimally invasive procedure, technological advancements, and changes in lifestyle (consumption of junk food, tobacco, and alcohol) are expected to boost the market growth.

However, high cost of treatment, complications associated with stent grafts, and lack of awareness in developing region restrain the market growth. Favorable reimbursements and development in healthcare infrastructure in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous growth opportunities for the market growth during the forecast period.

The report analyzes the global stent grafts market based on product, application, type, and geography. In terms of product, the market is divided into endovascular and synthetic stent graft system. Applications covered in the study include abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of type, the market is categorized into aorta-uni-iliac (AUI) and bifurcated stent grafts.

Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Thailand, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, and rest of LAMEA).

Key players operating in the market include Cook Medical Inc., Endologix, Inc., W. L. Gore & Associates, Inc., Medtronic plc, C. R. Bard, Inc., Lombard Medical, Inc., Terumo Corporation, MicroPort Scientific Corporation, Merit Medical, B. Braun Melsungen AG, and Lifetech Scientific (Shenzhen) Co. Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
  • The report offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Exhaustive analysis by product, application, and type helps to understand the products used and the variants that are expected to gain prominence in the future.

 Key Market Segments

  • By Product
    • Endovascular
    • Synthetic Stent Graft System
  • By Application
    • Abdominal Aortic Aneurysm (AAA)
    • Thoracic Aortic Aneurysm (TAA)
  • By Type
    • Aorta-uni-iliac (AUI) Stent Grafts
    • Bifurcated Stent Grafts
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Medtronic plc.
  • Terumo Corporation
  • W. L. Gore and Associates, Inc.
  • Lombard Medical, Inc.
  • Endologix, Inc.
  • Merit Medical
  • C. R. Bard, Inc.
  • MicroPort Scientific Corporation
  • Cook Medical Inc.
  • B. Braun Melsungen AG

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: STENT GRAFTS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Endovascular

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Synthetic Stent Graft System

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: STENT GRAFTS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Abdominal Aortic Aneurysm (AAA)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Thoracic Aortic Aneurysm (TAA)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: STENT GRAFTS MARKET, BY TYPE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Type

    • 6.2. Aorta-uni-iliac (AUI) Stent Grafts

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Bifurcated Stent Grafts

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: STENT GRAFTS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Type

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Stent Grafts Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Type

      • 7.2.7. Canada Stent Grafts Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Type

      • 7.2.8. Mexico Stent Grafts Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Type

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Type

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Stent Grafts Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Type

      • 7.3.7. Germany Stent Grafts Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Type

      • 7.3.8. Italy Stent Grafts Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Type

      • 7.3.9. Spain Stent Grafts Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Type

      • 7.3.10. UK Stent Grafts Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Type

      • 7.3.11. Russia Stent Grafts Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Type

      • 7.3.12. Rest Of Europe Stent Grafts Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Type

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Type

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Stent Grafts Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Type

      • 7.4.7. Japan Stent Grafts Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Type

      • 7.4.8. India Stent Grafts Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Type

      • 7.4.9. South Korea Stent Grafts Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Type

      • 7.4.10. Australia Stent Grafts Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Type

      • 7.4.11. Thailand Stent Grafts Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Type

      • 7.4.12. Malaysia Stent Grafts Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Type

      • 7.4.13. Indonesia Stent Grafts Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Type

      • 7.4.14. Rest of Asia Pacific Stent Grafts Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Type

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Type

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Stent Grafts Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Type

      • 7.5.7. South Africa Stent Grafts Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Type

      • 7.5.8. Saudi Arabia Stent Grafts Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Type

      • 7.5.9. UAE Stent Grafts Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Type

      • 7.5.10. Argentina Stent Grafts Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Type

      • 7.5.11. Rest of LAMEA Stent Grafts Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Type

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Cook Medical Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Endologix, Inc.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. W. L. Gore And Associates, Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Medtronic Plc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. C. R. Bard, Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Lombard Medical, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Terumo Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. MicroPort Scientific Corporation

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Merit Medical

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. B. Braun Melsungen AG

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Lifetech Scientific (Shenzhen) Co. Ltd.

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL STENT GRAFTS MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL STENT GRAFTS MARKET FOR ENDOVASCULAR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL STENT GRAFTS MARKET FOR SYNTHETIC STENT GRAFT SYSTEM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL STENT GRAFTS MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL STENT GRAFTS MARKET FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL STENT GRAFTS MARKET FOR THORACIC AORTIC ANEURYSM (TAA), BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL STENT GRAFTS MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL STENT GRAFTS MARKET FOR AORTA-UNI-ILIAC (AUI) STENT GRAFTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL STENT GRAFTS MARKET FOR BIFURCATED STENT GRAFTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL STENT GRAFTS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA STENT GRAFTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 15. U.S. STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. U.S. STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. U.S. STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. CANADA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. CANADA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. CANADA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE STENT GRAFTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. ITALY STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. ITALY STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. ITALY STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. SPAIN STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. UK STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. UK STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. UK STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. RUSSIA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. RUSSIA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. REST OF EUROPE STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. ASIA-PACIFIC STENT GRAFTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. CHINA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. CHINA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. CHINA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. JAPAN STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. JAPAN STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. INDIA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. INDIA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. INDIA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH KOREA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH KOREA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. AUSTRALIA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. AUSTRALIA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. THAILAND STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. THAILAND STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. MALAYSIA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. MALAYSIA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. INDONESIA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. INDONESIA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. REST OF ASIA PACIFIC STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 80. LAMEA STENT GRAFTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 81. LAMEA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 84. BRAZIL STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 85. BRAZIL STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 87. SOUTH AFRICA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH AFRICA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 90. SAUDI ARABIA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. SAUDI ARABIA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 93. UAE STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 94. UAE STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. UAE STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 96. ARGENTINA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. ARGENTINA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 99. REST OF LAMEA STENT GRAFTS, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 100. REST OF LAMEA STENT GRAFTS, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA STENT GRAFTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 102. COOK MEDICAL INC.: KEY EXECUTIVES
  • TABLE 103. COOK MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 104. COOK MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 105. COOK MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 106. COOK MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. ENDOLOGIX, INC.: KEY EXECUTIVES
  • TABLE 108. ENDOLOGIX, INC.: COMPANY SNAPSHOT
  • TABLE 109. ENDOLOGIX, INC.: OPERATING SEGMENTS
  • TABLE 110. ENDOLOGIX, INC.: PRODUCT PORTFOLIO
  • TABLE 111. ENDOLOGIX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. W. L. GORE AND ASSOCIATES, INC.: KEY EXECUTIVES
  • TABLE 113. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
  • TABLE 114. W. L. GORE AND ASSOCIATES, INC.: OPERATING SEGMENTS
  • TABLE 115. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
  • TABLE 116. W. L. GORE AND ASSOCIATES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 118. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 119. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 120. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 121. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. C. R. BARD, INC.: KEY EXECUTIVES
  • TABLE 123. C. R. BARD, INC.: COMPANY SNAPSHOT
  • TABLE 124. C. R. BARD, INC.: OPERATING SEGMENTS
  • TABLE 125. C. R. BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 126. C. R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. LOMBARD MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 128. LOMBARD MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 129. LOMBARD MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 130. LOMBARD MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 131. LOMBARD MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 133. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 134. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 135. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 138. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 139. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 140. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 141. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. MERIT MEDICAL: KEY EXECUTIVES
  • TABLE 143. MERIT MEDICAL: COMPANY SNAPSHOT
  • TABLE 144. MERIT MEDICAL: OPERATING SEGMENTS
  • TABLE 145. MERIT MEDICAL: PRODUCT PORTFOLIO
  • TABLE 146. MERIT MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 148. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 149. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 150. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 151. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: KEY EXECUTIVES
  • TABLE 153. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: COMPANY SNAPSHOT
  • TABLE 154. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: OPERATING SEGMENTS
  • TABLE 155. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 156. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL STENT GRAFTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL STENT GRAFTS MARKET
  • FIGURE 3. SEGMENTATION STENT GRAFTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN STENT GRAFTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALSTENT GRAFTS MARKET
  • FIGURE 11. STENT GRAFTS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. STENT GRAFTS MARKET FOR ENDOVASCULAR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. STENT GRAFTS MARKET FOR SYNTHETIC STENT GRAFT SYSTEM, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. STENT GRAFTS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. STENT GRAFTS MARKET FOR ABDOMINAL AORTIC ANEURYSM (AAA), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. STENT GRAFTS MARKET FOR THORACIC AORTIC ANEURYSM (TAA), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. STENT GRAFTS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 18. STENT GRAFTS MARKET FOR AORTA-UNI-ILIAC (AUI) STENT GRAFTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. STENT GRAFTS MARKET FOR BIFURCATED STENT GRAFTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: STENT GRAFTS MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. COOK MEDICAL INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. COOK MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. COOK MEDICAL INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. ENDOLOGIX, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. ENDOLOGIX, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. ENDOLOGIX, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. W. L. GORE AND ASSOCIATES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. MEDTRONIC PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. C. R. BARD, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. C. R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. C. R. BARD, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. LOMBARD MEDICAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. LOMBARD MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. LOMBARD MEDICAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. TERUMO CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. MERIT MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. MERIT MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. MERIT MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. LIFETECH SCIENTIFIC (SHENZHEN) CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Stent Grafts Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved